Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated wound healing in diabetic ulcers by Sitagliptin
2015-005226-19Phase 4Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin in diabetic foot ulcer (DFU) and type 2 diabetes mellitus (T2DM), sponsored by Medical University of Innsbruck. Primary endpoint: Ulcer size. Started Jul 2016; status: terminated.
02
Drugs
sitagliptin
03
Conditions
diabetic foot ulcer (DFU)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005226-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005226-19.